Who are Scenic Biotech's investors?

Scenic Biotech's investors include BioGeneration Ventures, BioMedPartners, EIR Ventures, Inkef, Oxford Science Enterprises.

Scenic Biotech

5 known investors

Find your way into Scenic Biotech

Your email: who you already know at Scenic Biotech, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Scenic Biotech team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations. The company uses its proprietary Cell-seq platform to develop small molecule programs for genetic disorders.

AI & Machine Learning Biotech Deep Tech Digital Health Healthtech

Investors · 5

BioGeneration Ventureslisted by BioGeneration VenturesNaarden

How we know: BioGeneration Ventures's portfolio page · funding news · pharmafile.com · Not right? Tell us

BioMedPartnerslisted by BioMedPartnersBasel · $648K – $6.5M

How we know: BioMedPartners's portfolio page · the VCSheet dataset · Not right? Tell us

EIR Ventureslisted by EIR VenturesStockholm

How we know: funding news · Not right? Tell us

Inkeflisted by InkefAmsterdam

How we know: Inkef's portfolio page · pharmafile.com · the VCSheet dataset · Not right? Tell us

Oxford Science Enterpriseslisted by Oxford Science EnterprisesOxford · $63.5K – $31.8M

How we know: Oxford Science Enterprises's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountSeries AMar 2022
Source ↗
Undisclosed amountSeries AJul 2017
Source ↗
Undisclosed amountSeries AJun 2017
BioGeneration Ventures (lead), INKEF Capital (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Scenic Biotech went on to found or lead other companies.

Alexandra (Sandra) GlucksmannSenior AdvisorFounded Sensorium Therapeutics Michael WackerBoard DirectorFounded LimmaTech Biologics Alexander VosChairman of the BoardFounded VarmX

In the news

Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases - Scenic Biotechscenicbiotech.com · Mar 2022

Frequently asked questions

What does Scenic Biotech do?: Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations. The company uses its proprietary Cell-seq platform to develop small molecule programs for genetic disorders.
Who are Scenic Biotech's investors?: Scenic Biotech's investors include BioGeneration Ventures, BioMedPartners, EIR Ventures, Inkef, Oxford Science Enterprises.